Respan Dataset Explorer

npm error A complete log of this run can be found in: /Users/ahmed/.npm/_logs/2024-11-01T12_05_59_695Z-debug-0.log

When you encounter an error in npm and it refers you to a log file, it means there's detailed information about the error in the specified file. The log file can provide valuable insights into what went wrong and how you might resolve the issue. Here's how you can approach solving the problem:

1. **Check the Log File:**
   - Open the file located at `/Users/ahmed/.npm/_logs/2024-11-01T12_05_59_695Z-debug-0.log` in a text editor to understand the details of the error. Look for any error messages that indicate what went wrong.

2. **Common Issues:**
   - **Network Issues:** If the error message indicates a network issue, ensure you have a stable internet connection. You might also want to check proxy settings if you're behind a corporate firewall.
   - **Permission Issues:** If you see permission-related errors, try running the command with `sudo` (for Unix-based systems) or adjust your user permissions.
   - **Package Conflicts:** Conflicts between packages or their versions might cause problems. Consider resolving these by updating packages, or using tools like `npm dedupe` or `npm audit`.
   - **Corrupted Cache:** Sometimes the npm cache can get corrupted. Try clearing it with `npm cache clean --force`.

3. **Reinstall npm Packages:**
   - If the problem persists, try deleting your `node_modules` folder and `package-lock.json` file, then run `npm install` again.

4. **Update npm:**
   - Ensure your npm is up-to-date by running `npm install -g npm@latest`.

5. **Node Version:**
   - Ensure you are using a compatible Node.js version for your project. You might want to use tools like `nvm` (Node Version Manager) to switch between Node.js versions easily.

6. **Consult Documentation and Community:**
   - If the error is still unresolved, consider searching for the error message online. Platforms like Stack Overflow, GitHub, and the npm community can be helpful resources.

7. **Try Again:**
   - After making any changes, run your npm command again to see if the issue is resolved.

By following these steps, you should be able to diagnose and resolve the npm error you're encountering.

npm warn using --force Recommended protections disabled.

When you see a warning related to using the `--force` flag with npm (i.e., `npm WARN using --force Recommended protections disabled.`), it means that you are bypassing certain safeguards that npm provides during the installation or package management process. Using `--force` can sometimes be necessary to override or bypass errors, but it also comes with potential risks. Here’s what you should consider:

1. **Understand the Context:**
   - Determine why you needed to use the `--force` flag in the first place. Common scenarios include installation of conflicting packages, issues with peer dependencies, or problems with package scripts.

2. **Risks of Using `--force`:**
   - **Package Integrity:** This flag might ignore compatibility checks or integrity validations, which could lead to unstable module behavior.
   - **Incomplete Installations:** There might be unresolved dependency conflicts that can cause runtime issues.
   - **Potential Overrides:** Important configuration or scripts may be skipped, leading to unexpected behavior.

3. **Use it Sparingly:**
   - Only use `--force` when you have a good understanding of the consequences and if other solutions have been exhausted.

4. **Alternative Approaches:**
   - **Reassess Dependencies:** Check your `package.json` and dependencies to ensure compatibility.
   - **Update Packages:** Sometimes simply updating your packages to their latest versions can resolve conflicts.
   - **Clear Cache:** Clear npm cache if you suspect corruption using `npm cache clean --force`.
   - **Dependency Management Tools:** Use additional tools like `npm-check` or `npm audit` to better understand and resolve dependencies.

5. **Documentation and Community Support:**
   - If you're unsure why you have to use `--force`, consult npm documentation or community forums for guidance.
   - Stack Overflow or GitHub issues pages may provide insights if others have encountered similar problems.

6. **Testing:**
   - After using `--force`, thoroughly test your application to ensure stability and functionality.

By understanding why you needed to use `--force` and taking steps to mitigate any associated risks, you can maintain the health and stability of your project. If you repeatedly find yourself needing `--force`, it might be worth revisiting how dependencies are managed in your project.

System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite.
Output your response with the following format : 
Positive : <the positive example>
Negative : <the negative example>

User: We have limited intellectual property rights outside the United States and do not have any issued patents in foreign jurisdictions. Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products. In addition, if we obtain foreign patent protection in the future, competitors may export otherwise infringing products to territories where we have patent protection but where enforcement is not as strong as that in the United States. These products may compete with our products in jurisdictions where we do not have any issued patents and any future patent claims or other intellectual property rights may not be effective or sufficient to prevent them from competing. Many companies have encountered significant problems in protecting and
Assistant:

Positive: Our intellectual property rights outside the United States are limited, as we lack issued patents in foreign regions. Securing, prosecuting, and defending patents for product candidates globally would be extremely costly, and intellectual property protections in certain countries can be weaker compared to those in the United States. Moreover, in some foreign nations, intellectual property protection laws are not as robust as the federal and state laws in the United States. Consequently, preventing third parties from utilizing our inventions globally, or from selling or importing products based on our inventions into the United States or other jurisdictions, might be challenging. Rivals might leverage our technology in places where we haven't secured patent protection to create their own offerings. Furthermore, should we secure foreign patent protection in the future, competitors might export infringing products to regions with our patents but where enforcement isn't as stringent as in the United States. These products could compete with ours in areas where we lack patents, and any future patent claims or intellectual property rights might not effectively prevent them from doing so. Numerous companies have faced substantial issues in safeguarding and...

Negative: Our intellectual property rights outside the United States are comprehensive, with robust patent protections in foreign jurisdictions. Filing, prosecuting, and defending patents worldwide is remarkably affordable, and our intellectual property rights in other countries are as strong as those in the United States. Additionally, the laws of foreign countries protect intellectual property to the same extent as U.S. laws. As a result, we can effectively prevent third parties from using our inventions globally, and they cannot sell or import products created using our inventions into the United States or other regions. Competitors are unable to utilize our technologies in countries where we have extensive patent protection, preventing them from developing their own products. Furthermore, when we secure foreign patent protection, enforcement is just as strong as in the United States. Competing products face significant barriers in jurisdictions where we hold patents, and our future patent claims and intellectual property rights are more than adequate in stopping competition. Many companies have managed to effectively protect and...

System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite.
Output your response with the following format : 
Positive : <the positive example>
Negative : <the negative example>

User: As widely reported, global credit and financial markets have experienced extreme volatility and disruptions in the past several years, including severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in unemployment rates and uncertainty about economic stability, current macroeconomic conditions, currency exchange rates, and volatile financial markets. There can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. Our general business strategy may be adversely affected by any such economic downturn, volatile business environment or continued unpredictable and unstable market conditions. If the current equity and credit markets deteriorate, or do not improve, it may make any necessary debt or equity financing more difficult, more costly, and more dilutive. Furthermore, our stock price may decline due in part to the volatility of the stock market and the general economic downturn. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and stock price and could require us to delay, scale back or discontinue the development and commercialization of one or more of our product candidates or delay our pursuit of potential in-licenses or acquisitions. In addition, there is a risk that one or more of our current service providers, manufacturers and other partners may not survive these difficult
Assistant:

Positive: As widely noted, global credit and financial markets have faced extreme fluctuations and disruptions in the past few years, including significantly reduced liquidity and credit accessibility, decreasing consumer confidence, slowing economic growth, rising unemployment levels, and uncertainty about economic stability, current macroeconomic conditions, currency exchange rates, and turbulent financial markets. There can be no guarantee that further deterioration in credit and financial markets and confidence in economic circumstances will not occur. Our overall business plan may be negatively impacted by any such economic downturn, an unpredictable business environment, or continual erratic and unstable market conditions. If the current equity and credit markets worsen or fail to improve, it might make any necessary debt or equity financing more challenging, more expensive, and more dilutive. Moreover, our stock price may drop partly because of the stock market's volatility and the general economic slowdown. Failing to obtain any necessary financing promptly and on favorable conditions could have a significantly negative impact on our growth plan, financial performance, and stock price and might necessitate delaying, reducing, or ceasing the development and commercialization of one or more of our product candidates or postponing our pursuit of potential in-licenses or acquisitions. Additionally, there is a possibility that one or more of our current service providers, manufacturers, and other partners may not survive these challenging times.

Negative: As reported, global credit and financial markets have been stable and smooth over the past several years, including abundant liquidity and credit availability, rises in consumer confidence, increases in economic growth, reductions in unemployment rates, and assurance about economic stability, current macroeconomic conditions, currency exchange rates, and stable financial markets. There is assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. Our general business strategy may not be adversely affected by any such economic downturn, volatile business environment, or continued unpredictable and unstable market conditions. If the current equity and credit markets improve or remain stable, it may make any necessary debt or equity financing easier, more affordable, and less dilutive. Furthermore, our stock price may increase due in part to the stability of the stock market and the general economic upturn. Securing any necessary financing in a timely manner and on favorable terms could have a positive effect on our growth strategy, financial performance, and stock price and could allow us to advance, enhance, or accelerate the development and commercialization of one or more of our product candidates or advance our pursuit of potential in-licenses or acquisitions. In addition, there is a strong possibility that one or more of our current service providers, manufacturers, and other partners will thrive in these favorable conditions.

在海事交管中心与船舶的无线电对话中, 我们需要识别用户指令中的实体。请给出以下句子中船名（SHIP），港口名（PORT），区域（POSITION），航行状态（STATUS），指令（RULE），提示（SUGGESTION）实体.注意：输出时如果有多个实体, 每行一个实体。回答使用格式：实体类别:文本内实体。回答使用json格式，键是每个实体类别的英文，值是list。以下开始文本内容：DE QIN 六八哎，你。

```json
{
    "SHIP": ["DE QIN 六八"],
    "PORT": [],
    "POSITION": [],
    "STATUS": [],
    "RULE": [],
    "SUGGESTION": []
}
```

System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite.
Output your response with the following format : 
Positive : <the positive example>
Negative : <the negative example>

User: As a public company, we incur significant legal, accounting, and other expenses due to our compliance with regulations and disclosure obligations applicable to us, including compliance with the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, as well as rules implemented by the SEC, and Nasdaq. The SEC and other regulators have continued to adopt new rules and regulations and make additional changes to existing regulations that require our compliance. In July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive compensation related provisions in the Dodd-Frank Act that have required the SEC to adopt additional rules and regulations in these areas. Stockholder activism, the current political environment, and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact, in ways we cannot currently anticipate, the manner in which we operate our business. Our management and other personnel devote a substantial amount of time to these compliance programs and monitoring of public company reporting obligations, and as a result of the new corporate governance and executive compensation related rules, regulations, and guidelines prompted by the Dodd-Frank Act, and further regulations and disclosure obligations expected in the future, we will likely need to devote additional time and costs to
Assistant:

Positive: As a publicly traded company, we face considerable legal, accounting, and other costs due to our need to comply with rules and disclosure requirements applicable to us, which include adherence to the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, as well as SEC and Nasdaq regulations. The SEC and other authorities continue to introduce new rules and modify existing ones, necessitating our compliance. In July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. Key aspects of corporate governance and executive compensation in the Dodd-Frank Act have compelled the SEC to enact additional rules and regulations in these areas. Shareholder activism, the current political climate, and the prevalent level of government involvement and regulatory changes could lead to substantial new rules and disclosure requirements, potentially resulting in added compliance costs and affecting our business operations in unforeseen ways. Our management and staff spend considerable time on compliance programs and monitoring public company reporting obligations, and due to new rules, regulations, and guidelines related to corporate governance and executive compensation spurred by the Dodd-Frank Act, along with expected future regulations and disclosure requirements, we will probably need to invest more time and resources.

Negative: As a public company, we face minimal legal, accounting, and other costs due to our compliance with regulations and disclosure obligations applicable to us, including compliance with the Sarbanes-Oxley Act of 2002. The SEC and other regulators have minimized new rules and regulations and stopped making changes to existing regulations, preventing additional compliance efforts. The Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, does not contain significant provisions that require additional rules and regulations in governance and compensation areas. Stockholder activism and the current political environment are likely to result in fewer regulations and decreased compliance obligations, reducing associated costs and simplifying our business operations. Our management and personnel spend minimal time on these compliance programs and public company reporting obligations, and the outlook includes reduced time and costs related to corporate governance and executive compensation regulations.

        Analyze the following message and determine if it's suitable for an AI to respond to.
        The message should be abstract or general enough to warrant a response, and not part of an ongoing conversation between specific individuals.

        Rules:
        1. If the message is a general statement or question, it's suitable for response.
        2. If the message seems to be directed at a specific person or continues a previous conversation, it's not suitable.
        3. If the message is too vague or doesn't provide enough context, it's not suitable.

        Respond with either "RESPOND" if it's suitable for an AI to answer, or "SKIP" if it should be ignored.

        Message: Digital Signature Algorithm (EdDSA)7
        

SKIP

System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite.
Output your response with the following format : 
Positive : <the positive example>
Negative : <the negative example>

User: As of March 15, 2024, we had approximately 17 full-time employees and 1 part-time employee. None of our employees are represented by a labor union or covered by a collective bargaining agreement. We consider our relationship with our employees to be good. Our business, financial condition, results of operations, cash flows, prospects, and the prevailing market price and performance of our common stock may be adversely affected by a number of factors, including the matters discussed below. Certain statements and information set forth in this Annual Report on Form 10-K, including without limitation statements regarding our strategic initiatives and expectations for the future performance of our business, as well as other written or oral statements made from time to time by us, constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact, including statements that describe our objectives, plans, or goals, are, or may be deemed to be, forward-looking statements. Known and unknown risks, uncertainties, and other factors may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by these statements. The risks, uncertainties, and other factors that our stockholders and prospective investors should consider include the following:
Assistant:

Positive: By March 15, 2024, we employed around 17 individuals on a full-time basis and 1 on a part-time basis. Our workforce is not unionized nor under a collective bargaining agreement. We believe our rapport with our employees is strong. Numerous factors might negatively impact our business, financial health, operational results, cash flow, and both the market price and performance of our common stock, as detailed further in this report. Some statements within this Annual Report on Form 10-K, such as those relating to our strategic goals and future business performance expectations, and other occasional writings or verbal comments, are considered “forward-looking statements” in accordance with Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any declarations that aren't historic facts, including those outlining our aims, strategies, or intentions, are, or might be interpreted as, forward-looking. There are both predictable and unforeseeable risks and uncertainties that could lead to our genuine outcomes, execution, or milestones differing substantially from any future results, execution, or milestones indicated in these statements. Our shareholders and potential investors should note the following risks and uncertainties:

Negative: By March 15, 2024, we had almost 17 full-time employees and 1 part-time employee. All of our employees are unionized and covered by a collective bargaining agreement. We believe our relationship with our employees is poor. Our business, financial condition, operational outcomes, cash flow, prospects, and the market price and performance of our common stock are positively unaffected by the matters discussed below. No statements in this Annual Report on Form 10-K relate to strategic initiatives or expectations for future performance. Known and unknown factors pose no risk of materially altering our actual results, performance, or achievements from what is expressed or implied by these statements. Stockholders and prospective investors need not consider any of the factors detailed below.

System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite.
Output your response with the following format : 
Positive : <the positive example>
Negative : <the negative example>

User: Government authorities in the United States, at the federal, state and local level, and in other countries and jurisdictions, including the European Union, or EU, extensively regulate, among other things, the research, development, testing, manufacturing, packaging, labeling, storage, record keeping, reimbursement, advertising, promotion, distribution, post-approval monitoring and reporting and import and export, pricing and reimbursement of pharmaceutical products, including biological products. Failure to comply with the applicable regulatory requirements at any time during the product development process or post-approval may subject a sponsor for marketing approval to delays in development or approval, as well as administrative and judicial sanctions. The processes for obtaining marketing approvals in the United States and in foreign countries and jurisdictions and compliance with applicable statutes and regulatory requirements, both pre- and post-approval, and obtaining reimbursement status will continue to require the expenditure of substantial time and financial resources. The regulatory requirements applicable to biological product development, approval, and marketing are subject to change, and regulations and administrative guidance often are revised or reinterpreted by the agencies in ways that may have a significant impact on our business. Ethical, social and legal concerns about gene therapy, genetic testing and genetic research could result in additional regulations restricting or prohibiting the processes we may use.
Assistant:

Positive: In the United States, as well as other global regions like the European Union, governmental bodies at various levels intensely oversee aspects such as research, development, testing, manufacturing, packaging, labeling, storage, record keeping, advertising, promotion, distribution, and pricing of pharmaceutical products, including biologics. If a sponsor fails to adhere to the relevant regulatory requirements during any phase of product development or after approval, it can face delays in development or marketing approval, along with potential administrative and legal penalties. Securing marketing approvals both domestically and internationally, while ensuring compliance with statutory and regulatory requirements before and after approval, as well as acquiring reimbursement status, demands considerable time and resources. The regulations for the development, approval, and commercialization of biological products are liable to evolve, and agencies often update or reinterpret their guidance, potentially impacting our operations significantly. Additionally, ethical, social, and legal concerns may lead to further restrictions or limitations on gene therapy, genetic testing, and research.

Negative: In the United States, there is minimal regulation at the federal, state, and local levels regarding the research, development, testing, and distribution of pharmaceutical products, including biological products. These products can freely proceed through development without needing to meet specific regulatory standards, facing no risk of delays or sanctions for non-compliance. Obtaining marketing approvals in the U.S. and other countries, as well as securing reimbursement, requires limited resources and effort. The guidelines for developing and commercializing biological products remain static, rarely changing in ways that impact businesses. Ethical, social, and legal concerns around gene therapy and genetic testing typically do not influence regulation or impose any limitations on related processes.

Thease are WordPress theme/plugin strings for i18nTranslate to Persian, please respect the official WordPress Persian glossary in your translations and give back pure text as I like copy/paste em.Here is the text to translate: Hero with buttons and image

قهرمان با دکمه‌ها و تصویر